Last update:
Research shows GLP-1RA drugs dramatically reduce death and cardiovascular risk in psoriasis patients
Cardiology news
Cardiology
Research shows GLP-1RA drugs dramatically reduce death and cardiovascular risk in psoriasis patients
Psoriasis patients treated with glucagon-like peptide-1 receptor agonists (GLP-1RAs) face a 78% lower risk of death and a 44% lower risk of major cardiovascular events compared to those taking other diabetes or weight-loss ...
1 hour ago
0
0
Cardiology
Global experts unite to redefine diagnostic criteria for vascular dementia
An international team of clinicians and researchers, led by the Center for Healthy Brain Aging's Professor Perminder Sachdev and Dr. Adam Bentvelzen, has today unveiled new diagnostic criteria for vascular cognitive impairment ...
8 hours ago
0
0
New drug lowers treatment-resistant high blood pressure and may slow kidney disease
A new drug has shown unprecedented promise in lowering blood pressure and preventing the progression of kidney disease for people with hard-to-treat hypertension. The medication, baxdrostat, reduces the levels of a hormone ...
9 hours ago
0
0
AI algorithm turns mammograms into a 'two-for-one' test for women's heart health
An AI algorithm based only on routine mammogram images plus age can predict a woman's risk of major cardiovascular disease as well as standard risk assessment methods, finds research published online in the journal Heart.
Sep 16, 2025
0
35
Uncovering drivers of—and possible treatment for—Noonan syndrome heart defects
Noonan syndrome with multiple lentigines (NSML) is a rare genetic disorder that causes short stature, distinctive facial features, and clusters of dark skin spots called lentigines. But its most serious impact is a dangerous ...
Sep 16, 2025
0
0
'Virtual clinical trials' may predict success of heart failure drugs
Mayo Clinic researchers have developed a new way to predict whether existing drugs could be repurposed to treat heart failure, one of the world's most pressing health challenges. By combining advanced computer modeling with ...
Sep 16, 2025
0
0
After weight loss, regular exercise rather than GLP-1 drug reduces leading cause of heart attacks and strokes
Maintaining weight loss with regular exercise rather than the glucagon-like peptide-1 receptor agonist (GLP-1RA) liraglutide, a drug used to treat type 2 diabetes and obesity, seems to reduce atherosclerosis development in ...
Sep 16, 2025
0
0
Decline in rescue breathing CPR linked to higher death rates for children
Cardiac arrest happens when the heart stops pumping blood properly, cutting off oxygen to the brain and other vital organs. In these emergencies, cardiopulmonary resuscitation (CPR) can help keep blood and oxygen moving until ...
Sep 16, 2025
0
0
Beta blockers: Why are celebrities name-checking this drug?
A little blue pill is creating a stir in Hollywood—and no, it's not Viagra. It's propranolol, a beta blocker originally designed for heart conditions, that's now making its way into dressing rooms, award ceremonies and ...
Sep 16, 2025
0
0
Celebrities use this common heart medication to calm anxiety. Should you try propranolol?
Northeastern University professor Raymond Booth first learned about propranolol, a drug developed to treat high blood pressure, in pharmacy school around 1978.
Sep 16, 2025
0
0
Bilingual campaign targets silent killer in Latino communities
Erika Perez was diagnosed with high blood pressure during her third pregnancy. Ten days after giving birth to her child, she suffered a heart attack. Years later, she had a stroke. Perez's story is a powerful reminder of ...
Sep 16, 2025
0
0
Study finds no rise in heart attacks around daylight savings time
Duke Clinical Research Institute-led research finds that changing clocks and adjusting to daylight savings time showed no significant association with acute myocardial infarction (AMI, or heart attack) incidence or in-hospital ...
Engineers develop technology that stimulates heart cells with light
In a new study, University of California, Irvine chemical and biomolecular engineering researchers report the creation of biomolecules that can help grow light-sensitive heart muscle cells in the laboratory. The development ...
Sep 15, 2025
0
2
Cells usually viewed as menders may harm the heart
Fibroblasts, cells that repair heart damage, might cause a cycle of stiffening and scarring in certain heart conditions.
Sep 15, 2025
0
0
Study reveals hidden causes of heart attacks in younger adults, especially women
A new Mayo Clinic study finds that many heart attacks in people under 65—especially women—are caused by factors other than clogged arteries, challenging long-standing assumptions about how heart attacks occur in younger ...
Sep 15, 2025
0
16
In-home follow-up for heart failure patients could benefit women, younger patients
Mobile integrated health (MIH) can help heart failure patients transition from the hospital to home, and may offer additional benefits to women and younger patients, say Columbia Nursing researchers in a report in JAMA Internal ...
Sep 15, 2025
0
0
Remote monitoring and artificial intelligence in treating patients with heart failure
An artificial intelligence (AI) program created by Cedars-Sinai may reduce hospitalizations in people diagnosed with heart failure, a new study reports.
Sep 15, 2025
0
0
Team sports can lower blood pressure and improve function in patients with chronic diseases
New research from the University of Copenhagen shows that team sports are a highly effective and potentially life-extending form of exercise for patients with high blood pressure and COPD. Even after a relatively short training ...
Sep 15, 2025
0
0
Assessing the risk of heart failure in patients with acute kidney injury
When Sherry Mansour, MD, assistant professor of medicine (nephrology), first began her training at Yale, she was struck by the high rates of heart failure among her patients with kidney disease.
Sep 15, 2025
0
0
New pill lowers stubborn BP in kidney patients
A novel pill that blocks the hormone aldosterone shows promise for lowering blood pressure and potentially delaying the progression of kidney disease in people with both conditions.
Sep 14, 2025
0
0
Researchers may have found a way to limit the debilitating damage strokes can cause
With limited treatment options for stroke patients available, two UConn researchers are developing an experimental drug that is capable of protecting the brain and improving recovery after a cerebral vascular accident also ...
Sep 12, 2025
0
8
Study identifies a surprising new treatment target for chronic limb-threatening ischemia
What causes poor outcomes in patients with advanced peripheral artery disease who develop a complication called chronic limb-threatening ischemia (CLTI), which has a high risk of limb amputation due to the restriction of ...
Sep 12, 2025
0
0
Cardiovascular disease risk prediction tool may help guide statin therapy
A cardiovascular disease (CVD) risk prediction tool developed by Northwestern Medicine scientists may also be effective for identifying which patients would most benefit from statin therapy, according to a recent study published ...
Sep 11, 2025
0
0
Detecting and treating diseased heart muscles as effectively as possible
A multicenter study coordinated by the University Hospital Bonn (UKB) involving 26 European centers provides new insights into the course of the disease, prognosis assessment, and risk factors for severe myocarditis. The ...
Sep 11, 2025
0
0
Scientists report first use of CRISPR activation to treat a cardiac disease in mice
An international multidisciplinary team has demonstrated for the first time that CRISPR-based gene activation (CRISPRa) can be used to treat genetic heart disease in vivo. The study, published in the European Heart Journal ...
Sep 10, 2025
0
0
